Smith & Nephew (SNNUF) Shares Outstanding (Weighted Average) (2009 - 2025)
Smith & Nephew (SNNUF) reported Shares Outstanding (Weighted Average) of $175.0 million for Q4 2025, little changed on a YoY basis from $175.0 million in Q4 2024, and little changed quarter-over-quarter from $175.0 million in Q2 2025.
Smith & Nephew (SNNUF) Shares Outstanding (Weighted Average) (2009 - 2025) Analysis & Trends
Smith & Nephew has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $175.0 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $175.0 million; the trailing twelve-month figure through Dec 2025 stood at $175.0 million (changed 0.0% YoY), and the FY2025 full-year result was $175.0 million, changed 0.0% from the prior year.
- Shares Outstanding (Weighted Average) for Q4 2025 stood at $175.0 million, roughly flat from $175.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $872.0 million in Q4 2022, with the low at $175.0 million in Q2 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $374.3 million across 5 years, with a median of $175.0 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) jumped 392.66% — and 2024, when it sank 79.91%.
- Smith & Nephew's Shares Outstanding (Weighted Average) stood at $177.0 million in 2021, then soared by 392.66% to $872.0 million in 2022, then decreased by 0.11% to $871.0 million in 2023, then slumped by 79.91% to $175.0 million in 2024, then changed by 0.0% to $175.0 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $175.0 million (Q4 2025), $175.0 million (Q2 2025), and $175.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Smith & Nephew | - | - | - | 175.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 175.00 Mn |
| Jun 28, 2025 | 175.00 Mn |
| Dec 31, 2024 | 175.00 Mn |
| Jun 29, 2024 | 175.00 Mn |
| Dec 31, 2023 | 871.00 Mn |
| Dec 31, 2022 | 872.00 Mn |
| Dec 31, 2021 | 177.00 Mn |
| Dec 31, 2020 | 177.00 Mn |
| Jun 30, 2020 | 177.00 Mn |
| Dec 31, 2019 | 177.00 Mn |
| Jun 29, 2019 | 177.00 Mn |
| Dec 31, 2018 | 873.00 Mn |
| Jun 30, 2018 | 178.00 Mn |
| Dec 31, 2017 | 874.00 Mn |
| Dec 31, 2016 | 890.00 Mn |
| Dec 31, 2015 | 894.00 Mn |
| Jun 30, 2015 | 183.00 Mn |
| Dec 31, 2014 | 56.10 Mn |
| Sep 30, 2014 | 184.00 Mn |
| Jun 28, 2014 | 184.00 Mn |